Ombitasvir/Paritaprevir/Ritonavir plus Dasabuvir are Safety and Eficacy for Treating HCV GT1 and 4 Infection in Patients with Severe Renal Impairment or End-Stage Renal Disease: A Mulcicenter ExperienceRozas Gomez, I. Fernández, Estebes Hernandez et al.|Journal of Hepatology|2016Cited by 8
HIV Coinfection Predicts Failure of Ledipasvir/Sofosbuvir in Treatment-Naïve Noncirrhotic Patients With HCV Genotype 1Juan Berenguer, Juan González‐García, Antonio Olveira et al.|Open Forum Infectious Diseases|2019Cited by 4